Former European commissioner forges new career advising corporate clients
Three years after he lost EU trade commissionership during the Golfgate affair, Phil Hogan has notified authorities of his new work. Photograph: Eric Lukehas declared some €1 million in annual revenues from his consultancy firm, as he forges a new career advising big-league corporate clients.affair, Mr Hogan has set out his fee income for client work in an official filing to the authorities in Brussels.
Mr Hogan also declared revenues between €100,000 and €199,999 from JP Morgan, the US banking giant, and revenues in that range from DLA Piper, a global law firm with lawyers in more than 40 countries. Brussels had placed strict limits on the firm’s activity by saying he could not lobby the European Commission or advise clients on trade or agriculture until the second anniversary of his resignation, which was in August 2022.
The main EU legislative proposals or policies targeted are in financial, banking, sustainability and telecommunications areas, as well as energy security, health and proposals linked to the “general sustainability” agenda.
España Últimas Noticias, España Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
US gives Ukraine 1.1m rounds of ammunition amid fears over waning support from WestAmmunition was seized from Iran last December by naval vessels of US central command
Leer más »
House Tour: A former artist’s studio turned into a Clontarf homeInterior designer Caroline Flannery takes an unusual project, a former artist's studio, on for her own home.
Leer más »
Former St Conleth’s College pupil dismisses school’s statement about ex-Nazi teacherUki Goñi says St Conleth’s has not gone far enough in addressing the presence of a former SS officer
Leer más »
Former contact lens factory employee awarded €275,000 over work accidentMargaret Reid suffered injury to her shoulder and neck after a metal container fell from a height
Leer más »
Drugmaker GSK Sells €1bn stake in former consumer health unit HaleonBritish medicines group and US rival Pfizer have both committed to selling down stakes over time to fund core pharma operations
Leer más »